GI imaging update organised by the BIR Scottish Branch

26th February 2021  09:00 AM - 05:00 PM (GMT+00:00) GMT

Due to COVID-19 (Coronavirus),  this event has now been rescheduled to be held on 26 March 2021 in Edinburgh. All delegates currently booked on this event have been transferred to the new date and informed by email.

Please view our COVID-19 update page for further information. 


This one-day event will cover various aspects of gastrointestinal imaging including diagnosis of common pathological conditions through utilising different imaging modalities. It will highlight several new diagnostic strategies and imaging modalities related to the gastrointestinal.

 

It is suitable for radiologists – both consultants and trainees – as well as for allied health professionals with an interest in the area such as radiographers.

 

Educational aims:

  • To keep updated on the current knowledge in diagnostic gastrointestinal radiology
  • To keep up-to-date with emerging diagnostic strategies
  • To provide an overview of image guided intervention in the gastrointestinal

 

View full event programme

 

Registration fees

BIR member Plan 1 £90

BIR member Plan 2 £70

BIR Trainee member £70

BIR Retired/Student member £40

Non-member £125

Venue

Speakers

Sponsors

Advanced Accelerator Applications

Advanced Accelerator Applications, S.A. (AAA), a Novartis company, is an innovative medicines company developing targeted radioligand therapies and precision imaging radioligands for oncology. We are committed to transforming patients’ lives by leading innovation in nuclear medicine. AAA currently has over 1,000 employees working across 31 sites in 12 countries (Canada, France, Germany, Israel, Italy, the Netherlands, Poland, Portugal, Spain, Switzerland, the UK and the US). The company also has global manufacturing capabilities with 19 facilities in eight countries, and six research & development sites. For more information, please visit: https://www.adacap.com/.

Bayer

Bayer’s Radiology business is well placed to be the partner of choice in helping NHS trusts to address the many challenges faced today including the increasing need for governance to demonstrate best practice and improving patient care within increasing financial constraints. With market-leading contrast media and power injector systems, Bayer is able to offer innovative patient care and with the addition of its informatics platform, it can support radiology departments in driving protocol standardisation and easily accessible audit data that enable departments to meet further challenges faced around contrast and radiation dose management. 0118 2063999 www.radiology.bayer.co.uk

GE Healthcare Ltd

GE Healthcare is a leading provider of medical imaging, monitoring, and life science technologies. GE Healthcare enables precision health in diagnostics, therapeutics and monitoring through intelligent devices, data analytics, applications and services to help providers, researchers and life sciences companies in their mission to improve outcomes for patients around the world.

Philips Healthcare

Enabling better health and better care at lower cost Philips is a leading health technology company focused on improving people`s lives across the health continuum - from healthy living and prevention, to diagnosis, treatment and home care. Applying advanced technologies and deep clinical and consumer insights, Philips delivers integrated solutions that improve people`s health and enable better outcomes. Partnering with its customers, Philips seeks to transform how healthcare is delivered and experienced. The company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. www.philips.co.uk/healthcare

Siemens Healthineers

At Siemens Healthineers, our purpose is to enable healthcare providers to increase value by empowering them on their journey towards expanding precision medicine, transforming care delivery, and improving patient experience, all enabled by digitalising healthcare. An estimated 5 million patients globally everyday benefit from our innovative technologies and services in the areas of diagnostic and therapeutic imaging, laboratory diagnostics and molecular medicine, as well as digital health and enterprise services. We are a leading medical technology company with over 170 years of experience and 18,000 patents globally. With more than 48,000 dedicated colleagues in 75 countries, we will continue to innovate and shape the future of healthcare. For more information and latest product line, please visit www.siemens-healthineers.com/en-uk/